Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
EVANSTON, Ill., Jan. 14, 2020 (GLOBE NEWSWIRE) — Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the […]